A separate analysis of the hematological cancer cell lines showed multiple myeloma had the highest PLA2G4A copy number (Figure 3B) and that the highest PLA2G4A gene expression was in acute myeloid leukemia (AML) lines (Figure 3C). This evidence concerns the gene PLA2G4A and hematopoietic and lymphoid cell neoplasm.